These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 33548034)

  • 1. Prevalence and characteristics of Kawasaki disease before and during the COVID-19 pandemic.
    Ono R; Hasegawa D
    World J Pediatr; 2021 Apr; 17(2):215-217. PubMed ID: 33548034
    [No Abstract]   [Full Text] [Related]  

  • 2. Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis.
    Ouldali N; Pouletty M; Mariani P; Beyler C; Blachier A; Bonacorsi S; Danis K; Chomton M; Maurice L; Le Bourgeois F; Caseris M; Gaschignard J; Poline J; Cohen R; Titomanlio L; Faye A; Melki I; Meinzer U
    Lancet Child Adolesc Health; 2020 Sep; 4(9):662-668. PubMed ID: 32622376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severity predictors in pediatric SARS-CoV-2 and MIS-C.
    Zachariah P
    J Pediatr; 2021 May; 232():307-310. PubMed ID: 33896460
    [No Abstract]   [Full Text] [Related]  

  • 4. Incidence of Kawasaki disease before and during the COVID-19 pandemic: a retrospective cohort study in Japan.
    Iio K; Matsubara K; Miyakoshi C; Ota K; Yamaoka R; Eguchi J; Matsumura O; Okutani T; Ueda I; Nishiyama M
    BMJ Paediatr Open; 2021; 5(1):e001034. PubMed ID: 33884312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention Measures for COVID-19 and Changes in Kawasaki Disease Incidence.
    Katsumata N; Harama D; Toda T; Sunaga Y; Yoshizawa M; Kono Y; Hasebe Y; Koizumi K; Hoshiai M; Saito T; Hokibara S; Kobayashi K; Goto M; Sano T; Tsuruta M; Nakamura M; Mizorogi S; Ohta M; Mochizuki M; Sato H; Yokomichi H; Inukai T
    J Epidemiol; 2021 Nov; 31(11):573-580. PubMed ID: 34483151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kawasaki disease or Kawasaki-like disease: Influence of SARS-CoV-2 infections in Japan.
    Iio K; Uda K; Hataya H; Yasui F; Honda T; Sanada T; Yamaji K; Kohara M; Itokawa M; Miura M
    Acta Paediatr; 2021 Feb; 110(2):600-601. PubMed ID: 32799392
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel coronavirus infection and Kawasaki disease.
    Bitsadze VO; Grigoreva K; Khizroeva JK; Pervunina TM; Tsibizova VI; Tretyakova MV; Makatsariya AD
    J Matern Fetal Neonatal Med; 2022 Aug; 35(16):3044-3048. PubMed ID: 32731783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kawasaki disease recurrence in the COVID-19 era: a systematic review of the literature.
    Medaglia AA; Siracusa L; Gioè C; Giordano S; Cascio A; Colomba C
    Ital J Pediatr; 2021 Apr; 47(1):95. PubMed ID: 33874991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Pandemic Sets New Clues on the Transmission Pathways in Kawasaki Disease.
    Rodó X; Fontal A
    JAMA Netw Open; 2021 Apr; 4(4):e214624. PubMed ID: 33822073
    [No Abstract]   [Full Text] [Related]  

  • 10. No relationship was observed between Kawasaki disease and COVID-19 in Japan.
    Nakamura Y;
    Pediatr Int; 2021 Aug; 63(8):977. PubMed ID: 33913588
    [No Abstract]   [Full Text] [Related]  

  • 11. Multisystem Inflammatory Syndrome in Children and Kawasaki Disease: Two Different Illnesses with Overlapping Clinical Features.
    Rowley AH
    J Pediatr; 2020 Sep; 224():129-132. PubMed ID: 32585239
    [No Abstract]   [Full Text] [Related]  

  • 12. Kawasaki Disease During COVID-19 Pandemic in Korea - Data Were Added but Are Needed More.
    Jo DS
    J Korean Med Sci; 2022 May; 37(20):e170. PubMed ID: 35607745
    [No Abstract]   [Full Text] [Related]  

  • 13. The novel coronavirus (COVID-19) and the risk of Kawasaki disease in children.
    Alizargar J
    J Formos Med Assoc; 2020 Nov; 119(11):1713-1714. PubMed ID: 32456973
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical characteristics of Kawasaki disease and concurrent pathogens during isolation in COVID-19 pandemic.
    Ding YY; Ren Y; Qin J; Qian GH; Tang YJ; Chen Y; Li X; Xu L; Qiao CH; Sun L; Lv HT
    World J Pediatr; 2021 Jun; 17(3):263-271. PubMed ID: 34160770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tracking awareness for Kawasaki disease in children related to the COVID-19 pandemic.
    Springer S; Strzelecki A; Zieger M
    Clin Rheumatol; 2021 Feb; 40(2):803-804. PubMed ID: 33428101
    [No Abstract]   [Full Text] [Related]  

  • 16. Kawasaki Disease During the SARS-CoV-2 Pandemic.
    Goyal A; Maheshwari A; Shakeel A; Saneja V; Kumar S; Mahto D
    Indian J Pediatr; 2022 Nov; 89(11):1157. PubMed ID: 36107289
    [No Abstract]   [Full Text] [Related]  

  • 17. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study.
    Verdoni L; Mazza A; Gervasoni A; Martelli L; Ruggeri M; Ciuffreda M; Bonanomi E; D'Antiga L
    Lancet; 2020 Jun; 395(10239):1771-1778. PubMed ID: 32410760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kawasaki Disease and Pediatric Infectious Diseases During the Coronavirus Disease 2019 Pandemic.
    Ae R; Shibata Y; Kosami K; Nakamura Y; Hamada H
    J Pediatr; 2021 Dec; 239():50-58.e2. PubMed ID: 34324881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emergence of a new cytokine storm during the COVID-19 pandemic: Multisystem inflammatory syndrome in children.
    Yang MC; Tsai CC; Su YT; Wu JR
    Kaohsiung J Med Sci; 2021 Mar; 37(3):255-256. PubMed ID: 33400372
    [No Abstract]   [Full Text] [Related]  

  • 20. Missed or delayed diagnosis of Kawasaki disease during the 2019 novel coronavirus disease (COVID-19) pandemic.
    Harahsheh AS; Dahdah N; Newburger JW; Portman MA; Piram M; Tulloh R; McCrindle BW; de Ferranti SD; Cimaz R; Truong DT; Burns JC
    J Pediatr; 2020 Jul; 222():261-262. PubMed ID: 32370951
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.